Quegen Biotech Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Employees
-
14
- Latest Deal Type
-
Out of Business
Quegen Biotech General Information
Description
Operator of a biotech company intended to produce cosmetic raw materials. The company utilizes biological resources to produce raw materials, providing clients with functional cosmetics as per their needs.
Contact Information
Website
www.quegen.comOwnership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
- 54, Mayu-ro 92beon-gil
- Siheung, Gyeonggi
- South Korea
Primary Industry
Personal Products
Vertical(s)
Corporate Office
- 54, Mayu-ro 92beon-gil
- Siheung, Gyeonggi
- South Korea
Quegen Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 10-Oct-2025 | Completed | Out of Business | |||
| 2. Later Stage VC (Series B) | 18-Mar-2019 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series B) | 23-Aug-2016 | Completed | Generating Revenue |
Quegen Biotech Patents
Quegen Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020246817-A1 | Gut flora-improving composition comprising beta-glucan and use thereof | Inactive | 07-Jun-2019 | ||
| WO-2020085735-A1 | Method for preparing bioconversion products of asparagus cochinchinensis and soybean embryos by means of liquid culturing of basidiomycetes mycelium, and use thereof | Inactive | 26-Oct-2018 | ||
| JP-2021531244-A | A pharmaceutical composition for wound healing or skin activation containing beta-glucan, glycitin and 4', 6,7-trimethoxyisoflavone. | Pending | 22-Jun-2018 | ||
| US-20210260096-A1 | Pharmaceutical composition for treating wound or activating skin, containing beta-glucan, glycitin, and 4',6,7-trimethoxyisoflavone | Inactive | 22-Jun-2018 | ||
| WO-2019245275-A1 | Composition, comprising β-glucan-peptide complex and antibiotic, for prevention, alleviation, or treatment of inflammatory disease | Inactive | 20-Jun-2018 | A23L33/21 |
Quegen Biotech Signals
Quegen Biotech FAQs
-
When was Quegen Biotech founded?
Quegen Biotech was founded in 2006.
-
Where is Quegen Biotech headquartered?
Quegen Biotech is headquartered in Siheung, South Korea.
-
What is the size of Quegen Biotech?
Quegen Biotech has 14 total employees.
-
What industry is Quegen Biotech in?
Quegen Biotech’s primary industry is Personal Products.
-
Is Quegen Biotech a private or public company?
Quegen Biotech is a Private company.
-
What is Quegen Biotech’s current revenue?
The current revenue for Quegen Biotech is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process